Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles

References

• LamKYLoCYMetastatic tumors of the thyroid gland: a study of 79 cases in Chinese patientsArch Pathol Lab Med1998122137419448014
   PubMedGoogle Scholar
• ChenHNicolTLUdelsmanRClinically significant, isolated metastatic disease to the thyroid glandWorld J Surg19992321771809880428
   PubMedGoogle Scholar
• RokaSKornekGSchüllerJOrtmannEFeichtingerJArmbrusterCCarcinoma showing thymic-like elements – a rare malignancy of the thyroid glandBr J Surg200491214214514760659
   PubMedGoogle Scholar
• MazzaferriELKloosRTClinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancerJ Clin Endocrinol Metab20018641447146311297567
   PubMed Web of Science ®Google Scholar
• Fard-EsfahaniAEmami-ArdekaniAFallahiBAdverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinomaNucl Med Commun201435880881724751702
   PubMed Web of Science ®Google Scholar
• WillegaignonJSapienzaMOnoCOutpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedureClin Nucl Med201136644044521552020
   PubMedGoogle Scholar
• ShermanSIThyroid carcinomaLancet2003361935650151112583960
   PubMed Web of Science ®Google Scholar
• AinKBAnaplastic thyroid carcinoma: behavior, biology, and therapeutic approachesThyroid1998887157269737368
   PubMed Web of Science ®Google Scholar
• NeumannSHuangWTitusSSmall-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and miceProc Natl Acad Sci U S A200910630124711247619592511
   PubMedGoogle Scholar
• Pujol-BorrellRGiménez-BarconsMMarín-SanchezAColobranRGenetics of Graves’ disease: special focus on the role of TSHR geneHorm Metab Res2015471075376626361261
   PubMedGoogle Scholar
• DorsamRTGutkindJSG-protein-coupled receptors and cancerNat Rev Cancer200772799417251915
   PubMed Web of Science ®Google Scholar
• YamamotoYSakamotoMFujiiGOverexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutationsHepatology200337352853312601349
   PubMed Web of Science ®Google Scholar
• YuYZhangQBuscagliaJQuantitative real-time detection of carcinoembryonic antigen (CEA) from pancreatic cyst fluid using 3-D surface molecular imprintingAnalyst2016141144424443127193921
   PubMedGoogle Scholar
• PaolinoDCoscoDGaspariMTargeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomesBiomaterials201435257101710924836306
   PubMedGoogle Scholar
• GaoXJLiAQZhangXLiuPWangJRCiaXThyroid-stimulating hormone (TSH)-armed polymer-lipid nanoparticles for the targeted delivery of cisplatin in thyroid cancers: therapeutic efficacy evaluationRsc Adv20155106413106420
   Google Scholar
• YuYZhangQChangCCDesign of a molecular imprinting biosensor with multi-scale roughness for detection across a broad spectrum of biomoleculesAnalyst2016141195607561727441317
   PubMedGoogle Scholar
• SunHGuoBChengRMengFLiuHZhongZBiodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicinBiomaterials200930316358636619666191
   PubMed Web of Science ®Google Scholar
• ChenWMengFChengRZhongZpH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micellesJ Control Release20101421404619804803
   PubMed Web of Science ®Google Scholar
• WangSShangLLiLMetal-organic-framework-derived mesoporous carbon nanospheres containing porphyrin-like metal centers for conformal phototherapyAdv Mater201628388379838727461987
   PubMed Web of Science ®Google Scholar
• FangWJYangJGongJWZhengNPhoto- and pH-triggered release of anticancer drugs from mesoporous silica-coated Pd@Ag nanoparticlesAdv Funct Mater201222842848
   Web of Science ®Google Scholar
• AhmedFPakunluRISrinivasGShrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradationMol Pharm20063334035016749866
   PubMed Web of Science ®Google Scholar
• LiuJBuWPanLShiJNIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silicaAngew Chem Int Ed Engl201352164375437923495013
   PubMed Web of Science ®Google Scholar
• OhKTOhYTOhNMKimKLeeDHLeeESA smart flower-like polymeric micelle for pH-triggered anticancer drug releaseInt J Pharm20093751–216316919481702
   PubMedGoogle Scholar
• HeCFWangSHYuYJAdvances in biodegradable nanomaterials for photothermal therapy of cancerCancer Biol Med201613329931227807498
   PubMed Web of Science ®Google Scholar
• NaskarJPaluiGBanerjeeATetrapeptide-based hydrogels: for encapsulation and slow release of an anticancer drug at physiological pHJ Phys Chem B200911335117871179219708711
   PubMed Web of Science ®Google Scholar
• DuCDengDShanLA pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug deliveryBiomaterials201334123087309723374705
   PubMed Web of Science ®Google Scholar
• LiuDFBernuzCRFanJA nano-in-nano vector: merging the best of polymeric nanoparticles and drug nanocrystalsAdv Funct Mater20172791604508
   Google Scholar
• LiuDZhangHCitoSCore/shell nanocomposites produced by superfast sequential microfluidic nanoprecipitationNano Lett201717260661428060521
   PubMed Web of Science ®Google Scholar
• LiuDZhangHMäkiläEMicrofluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapyBiomaterials20153924925925468375
   PubMed Web of Science ®Google Scholar
• LiuDZhangHHerranz-BlancoBMicrofluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug deliverySmall201410102029203824616278
   PubMed Web of Science ®Google Scholar
• LiYXiaoWXiaoKWell-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diolsAngew Chem Int Ed Engl201251122864286922253091
   PubMed Web of Science ®Google Scholar
• VaupelPKallinowskiFOkunieffPBlood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a reviewCancer Res19894923644964652684393
   PubMed Web of Science ®Google Scholar
• SawantRMHurleyJPSalmasoS“SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriersBioconjug Chem200617494394916848401
   PubMed Web of Science ®Google Scholar
• DengSYanTJendrnyCDexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoformsBMC Cancer20141484225406834
   PubMed Web of Science ®Google Scholar
• OlsonRDMushlinPSDoxorubicin cardiotoxicity: analysis of prevailing hypothesesFASEB J1990413307630862210154
   PubMed Web of Science ®Google Scholar
• OlsonRDMushlinPSBrennerDEDoxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolProc Natl Acad Sci U S A19888510358535892897122
   PubMed Web of Science ®Google Scholar
• ArolaOJSarasteAPulkkiKKallajokiMParvinenMVoipio-PulkkiLMAcute doxorubicin cardiotoxicity involves cardiomyocyte apoptosisCancer Res20006071789179210766158
   PubMed Web of Science ®Google Scholar
• KalyanaramanBJosephJKalivendiSWangSKonorevEKotamrajuSDoxorubicin-induced apoptosis: implications in cardiotoxicityMol Cell Biochem2002234–2351–2119124
   PubMed Web of Science ®Google Scholar
• PolegatoBFMinicucciMFAzevedoPSAcute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in ratsCell Physiol Biochem20153551924193325871735
   PubMedGoogle Scholar
• TomaykoMMReynoldsCPDetermination of subcutaneous tumor size in athymic (nude) miceCancer Chemother Pharmacol19892431481542544306
   PubMed Web of Science ®Google Scholar
• O’DonoghueJABardièsMWheldonTERelationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclidesJ Nucl Med19953610190219097562062
   PubMedGoogle Scholar
• HermannPCHuberSLHerrlerTDistinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancerCell Stem Cell20071331332318371365
   PubMed Web of Science ®Google Scholar